Skip to content

Zimmon G21426Recalls & reported problems

Cook Ireland Ltd · Zimmon, Pancreatic Stent Set · Class 2 · Implant

All models of Zimmon (43)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00827002214262), received between Sep 9, 2025 and Sep 9, 2025 — classified as 1 malfunction.

The most frequently reported specific device problem is “Improper or Incorrect Procedure or Method” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 1 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Improper or Incorrect Procedure or Method1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionSep 9, 2025Improper or Incorrect Procedure or Method; Improper or Incorrect Procedure or Method

    AFTER PLACING A GUIDEWIRE (BOSTON SCIENTIFIC/ENDOSELECTOR 0.025 INCH) IN THE PANCREATIC DUCT, WHEN ADVANCING A STENT OVER THE GUIDEWIRE, THE GUIDEWIRE DID NOT EXIT THE GUIDEWIRE LUMEN OF THE STENT BUT INSTEAD EXITED THE GUTTER, MAKING IT UNUSABLE. THE PROCEDURE CONTINUED USING A DIFFERENT MODEL GEPD (DETAIL UNKNOWN). THE PROCEDURE WAS COMPLETED WITHOUT ISSUE. NO HEALTH HAZARD. 1.DOES THE COMPLAINT RELATE TO: DEVICE PLACEMENT/DEVICE REMOVAL/OBSERVATION PRIOR TO PATIENT CONTACT DURING ADVANCING OVER A WIRE GUIDE. 2 WHAT WAS THE TARGET LOCATION FOR THE STENT? THE PANCREATIC DUCT. 3 PLEASE DESCRIBE THE STORAGE CONDITIONS OF THE DEVICE PRIOR TO USE ESPECIALLY THOSE PERTAINING TO TEMPERATURE AND LIGHT EXPOSURE. 4 WHAT IS THE REORDER NUMBER, OUTER DIAMETER AND LENGTH OF THE WIRE GUIDE THAT WAS USED WITH THIS DEVICE IN THIS PROCEDURE? BOSTON SCIENTIFIC/ENDOSELECTOR 0.025INCH. 5 WAS THE WIRE GUIDE LUBRICATED PRIOR TO USE? YES. 6 WAS THE DEVICE AT THE CENTRE OF THE COMPLAINT INSPECTED FOR DAMAGE PRIOR TO USE? YES. 7 WAS THE WIRE GUIDE INSPECTED FOR DAMAGE PRIOR TO USE? YES. 8 WERE PREVIOUS PROCEDURES I.E. SPHINCTEROTOMY ETC. CARRIED OUT PRIOR TO PLACING THE COMPLAINT DEVICE? UNKNOWN. 10 DID

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 23004331 ↗

Other CATHETER, BILIARY, DIAGNOSTIC devices

All CATHETER, BILIARY, DIAGNOSTIC devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page